Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2024.06.25.600622

Structural and mechanistic insights into Plasmodium eIF2alpha dephosphorylation by UIS2 during the erythrocytic stage

Wu, S.·Wagner, G.
View original source ↗Export metadata ↓

Abstract

UIS2 is a promising therapeutic target for malaria due to its essential role in the transmission and infectivity of Plasmodium to the host hepatocytes. In Plasmodium, UIS2 acts as a phosphatase toward phosphorylated eIF2alpha at Ser59, regulating translation initiation. However, its role during the erythrocytic stage, which causes clinical symptoms, remains unclear, and its protein structure for elucidating the dephosphorylation mechanism is unavailable. In this study, we analyzed the Plasmodium phenotype screening database and found that UIS2-deficient Plasmodium fails to proliferate during the erythrocytic stages. Single-cell transcriptomic data from the Malaria Cell Atlas revealed UIS2 expression during both hepatic and erythrocytic stages, with significant upregulation in trophozoites and late schizonts, suggesting UIS2s essential role in erythrocytic stage development. Structural analyses using AlphaFold modeling demonstrated that the UIS2 phosphatase domain (UIS2-PD) shares homology with human purple acid phosphatase, featuring conserved catalytic site residues. We observed that the N-terminal domain of UIS2 interacts with the S1 domain loop of a phospho-mimic mutant (Ser59Asp) eIF2alpha via electrostatic interactions. This protein interaction is distal to the phosphatase domain, indicating a unique substrate recruitment mechanism distinct from mammalian serine/threonine phosphatase PP1. Additionally, we identified a negatively charged cavity in UIS2-PD capable of binding the Ser59-containing loop in eIF2alpha for substrate recognition. Molecular docking studies showed that the phosphatase inhibitor salubrinal binds to this negatively charged cavity, potentially obstructing enzyme-substrate interactions. These structural insights into UIS2 and its interaction with eIF2alpha provide promising avenues for developing novel antimalarial drugs. Significance StatementMalaria poses a significant global health challenge, particularly with rising resistance to artemisinin therapies. This study reveals the critical role of UIS2 in Plasmodium proliferation during the symptomatic blood stage through phenotype screening and single-cell transcriptomics. We characterized the catalytic site within UIS2-PD and discovered a surface cavity for recognizing phosphorylated eIF2alpha by UIS2-PD, which can be inhibited by small molecules. Our findings identify UIS2 as a promising target for new antimalarial drugs, addressing both blood-stage parasites to alleviate clinical symptoms and liver-stage parasites for prophylactic treatment. This dual targeting strategy could prevent malaria onset post-exposure and reduce the overall parasite burden. The protein interaction between UIS2 and eIF2alpha is chemically targetable, facilitating the development of effective UIS2 inhibitors.

Explore related subjects

biochemistryPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wu, S., Wagner, G.. 2024-06-27. Structural and mechanistic insights into Plasmodium eIF2alpha dephosphorylation by UIS2 during the erythrocytic stage. https://doi.org/10.1101/2024.06.25.600622

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Hierarchical cysteine oxidation controls reversible amyloid formation in an ankyrin repeat protein

The formation of amyloids, including functional amyloids, is observed for an increasing number of proteins but the molecular mechanisms that control this structural transition remain poorly understood. Here we report that the kinase inhibitor protein P18 (drP18) from Danio rerio (zebrafish), which contains two cysteine residues, undergoes a complex and hierarchical redox switch that strictly governs reversible amyloid formation. We identify cysteine 50 (C50) acting as a regulatory residue. Upon oxidation, C50 forms an intramolecular disulfide bond with the executioner cysteine 128 (C128), thereby blocking it. C50 can become S-glutathionylated, and upon oxidation, C128 then forms intermolecular disulfides that lead to rapid transition into amyloid fibrils. S-glutathionylation of C50 therefore enables amyloid formation of drP18 and the outcome is oxidant-dependent with diamide, hydrogen peroxide, peroxymonocarbonate and hypothiocyanous acid each leading to amyloid assembly with distinct kinetics and morphologies. These amyloids are fully reversible, where disulfide reduction is leading to disassembly. Whereas monomeric drP18 inhibits CDK4-mediated retinoblastoma phosphorylation, the amyloid conformation abolishes this inhibition, and reduction restores both structure and function. Expression of drP18 in zebrafish embryos yields Congo red-positive, oxidation-dependent aggregates in vivo. Together, our findings show that a regulatory cysteine controls an executioner cysteine to induce reversible, functional amyloid formation, revealing that proteins can encode sophisticated mechanisms to control amyloid assembly.

biochemistry↗
bioRxiv2026

Snapshots from the Catalytic Landscape of Chalcone Isomerase

Chalcone isomerase (CHI) catalyzes the cyclization of 3-ring scaffolds of flavonoids, a class of plant-based natural products important for nutrition and disease prevention. A persistent question has been whether the enzyme uses dynamics to facilitate conformational rearrangements of substrates within the active site. To help resolve this question, CHI was crystallized with phloretin, a flexible substrate analogue that cannot undergo cyclization. The crystal structure possesses eight protein molecules per asymmetric unit, revealing different active site conformations that accommodate different bound conformers of phloretin. Together, the structural snapshots depict a series of coordinated, dynamic chemical interactions that lower barriers to substrate rearrangements approaching bond formation. Differential scanning fluorimetry combined with mutational analysis and enzyme kinetics further confirm that phloretin binds to the enzyme active site and that it acts as a competitive inhibitor of CHI. Together these findings answer outstanding questions about the flexibility and dynamics of CHI catalysis, information that may be useful for future biosynthetic design and enzyme engineering goals. Overall, this work supports a catalytic model in which the CHI enzyme operates as a dynamic ensemble of structures necessary to facilitate catalytic substrate rearrangements.

biochemistry↗
bioRxiv2026

Structures of pUG-fold RNA bound to DNMT1 reveal a mechanism for RNA-mediated epigenetic regulation

Many chromatin-associated proteins have been found to bind RNA as a means of epigenetic regulation. Specifically, DNA methyltransferase 1 (DNMT1), which maintains cytosine methylation at CpG dinucleotides, is inhibited by RNA at transcribed DNA loci in cells. However, the mechanisms by which RNA binds DNMT1 and inhibits its activity remain unknown. Here, we determine a series of cryogenic electron microscopy (cryo-EM) structures of human DNMT1 bound to pUG-fold RNA, a non-canonical G-quadruplex previously observed to inhibit activity, revealing two distinct RNA-binding modes. The pUG-fold RNA binds the surface of DNMT1 in its autoinhibited conformation across a positively charged surface between the methyltransferase domain and the CXXC domain, and it binds directly in the active site of an open DNMT1 conformation. RNA binding is sterically incompatible with substrate DNA engagement in both states. Our 2.5 [A] structure captures the intricate network of hydrogen bonds and electrostatic interactions between amino acids in the methyltransferase domain and the tetrad layers of pUG-fold RNA. Metadynamics molecular dynamics simulations provide an orthogonal view of the conformational landscape of DNMT1, revealing the two distinct RNA-binding modes. Furthermore, our analysis of published DNMT1 RIP-seq and eCLIP-seq data confirms that DNMT1-interacting RNAs in cells exhibit a strong propensity to form non-canonical G-quadruplex RNA structures. Collectively, our study provides the first structural basis for pUG-fold RNA recognition by a protein and illustrates how cryo-EM and AI-based methods for protein and RNA structure prediction synergize to inform the mechanism of RNA-mediated regulation of DNMT1.

biochemistry↗